Prospective Study of White Blood Cells

Recruiting now

Conditions studied: Autoimmune Diseases, Inflammation, Rejection; Transplant, Liver

In brief

The purpose of this study is to investigate white blood cells from volunteering donors to support the development of engineered regulatory T cell therapies.

Key facts

Study ID

NCT04838171

Run by

Quell Therapeutics Limited

People needed

10

Starts

2021-03-24

Expected to finish

2030-01-01

Last updated by the study team

2026-01-21

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

Where it is running

• Quell Investigator Site 01 — London, United Kingdom (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.